Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 8—August 2024
Dispatch

Crimean-Congo Hemorrhagic Fever Virus Kinetics in Serum, Saliva, and Urine, Iran, 2018

Malihe Metanat, Seyed Dawood Mousavi Nasab, Tahmineh Jalali, Fahimeh Bagheri Amiri, Neda Sadat Torab Jahromi, Mahsa Tavakoli, Mohammad Hassan Pouriayevali, Mohammad Mehdi Gouya, and Mostafa Salehi-VaziriComments to Author 
Author affiliations: University of Medical Sciences, Zahedan, Iran (M. Metanat, N.S. Torab Jahromi); Pasteur Institute of Iran, Tehran, Iran (S.D. Mousavi Nasab, T. Jalali, F. Bagheri Amiri, M. Tavakoli, M.H. Pouriayevali, M. Salehi-Vaziri); Iran University of Medical Sciences, Tehran (M.M. Gouya)

Main Article

Figure 2

Results of Crimean-Congo hemorrhagic fever virus antigen ELISA testing for serum (A), saliva (B), and urine (C) samples from 22 Crimean-Congo hemorrhagic fever patients in Iran, by days after onset of symptoms. Weak positive, optical density (OD) <1; moderate positive, OD 1–3; strong positive, OD >3.

Figure 2. Results of Crimean-Congo hemorrhagic fever virus antigen ELISA testing for serum (A), saliva (B), and urine (C) samples from 22 Crimean-Congo hemorrhagic fever patients in Iran, by days after onset of symptoms. Weak positive, optical density (OD) <1; moderate positive, OD 1–3; strong positive, OD >3.

Main Article

Page created: June 21, 2024
Page updated: July 29, 2024
Page reviewed: July 29, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external